DiaMedica Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

DiaMedica Therapeutics

11/08/2021 23:33

* DiaMedica Therapeutics Inc  DMAC.OQ  reported a quarterly
adjusted loss of 17 cents​​ per share for the quarter ended in
June. The mean expectation of six analysts for the quarter was
for a loss of 21 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* DiaMedica Therapeutics Inc's reported EPS for the quarter was
a loss of 17 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* DiaMedica Therapeutics Inc shares had fallen by 23.4% this
quarter and lost 66.4% so far this year.
* The company reported a quarterly loss of $3.27 million.
* Wall Street's median 12-month price target for DiaMedica
Therapeutics Inc is $26.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 10:33 p.m.  ​All
figures in US dollars unless otherwise stated